Published in Vaccine Weekly, July 5th, 2000
"The present in vivo study investigated the impact of a monoclonal antibody (MAb) directed against the intercellular adhesion molecule-1 (ICAM-1) on initial microvascular reperfusion injury after liver transplantation," wrote M. Rentsch and colleagues, Klinikum University Regensburg, Germany. "Orthotopic, syngeneic liver transplantation including arterial reconstruction was performed in male Lewis rats after 24 hour graft storage in University of Wisconsin (UW) solution at 4(degree)C."
Rentsch et al. published their study in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.